Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Aytu Biopharma (AYTU) Current Taxes (2020)

Aytu Biopharma (AYTU) has disclosed Current Taxes for 1 consecutive years, with $175000.0 as the latest value for Q2 2020.

On a quarterly basis, Current Taxes changed N/A to $175000.0 in Q2 2020 year-over-year; TTM through Jun 2020 was $175000.0, a N/A change, with the full-year FY2020 number at $175000.0, changed N/A from a year prior.
Current Taxes was $175000.0 for Q2 2020 at Aytu Biopharma.
In the past five years, Current Taxes ranged from a high of $175000.0 in Q2 2020 to a low of $175000.0 in Q2 2020.